Patent · US Active

Immunoglobulin chimeric monomer-dimer hybrids

US7862820B2 · kind B2 · utility

98Cited by
58References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 27, 2006
Grant dateJan 4, 2011
Priority date
Expiry dateSep 3, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to a chimeric monomer-dimer hybrid protein that comprises a first and a second polypeptide chain, the first polypeptide chain comprising at least a portion of an immunoglobulin constant region and a biologically active molecule, and the second polypeptide chain comprising at least a portion of an immunoglobulin constant region without the biologically active molecule of the first polypeptide chain. The invention also relates to methods of using and methods of making the chimeric monomer-dimer hybrid protein of the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.